Home > Newsroom > Updated News 
  New Genetically Recombined Hepatitis B Antibiotic ‘Hepabig-Gene’ Wins KFDA Approval for Phase I Clinical Trial
▶ Green Cross independently develops new genetically recombined Hepatitis B antibiotic therapy for the first time in the world. ▶ Will sa... 		 
  Green Cross Launches Neopecia, Male-pattern Hair Loss Remedy
▶ Economy added to Finasteride, orally taken hair loss formulation whose efficacy and safety have been proven. ▶ One tablet a day not o... 		 
 
71
 New Genetically Recombined Hepatitis B Antibiotic ‘Hepabig-Gene’ Wins KFDA Approval for Phase I Clinical Trial
2008-03-25
70
 Green Cross Launches Neopecia, Male-pattern Hair Loss Remedy
2008-03-20
69
 Green Cross Introduces Hansaplast, Europe’s No. 1 First-Aid Gauze Bandage
2008-02-13
68
 Green Cross Explores 3-Dimensional Structure of Blood Coagulation Factor III Gene for the First Time in the World
2008-02-04
67
 Green Cross Actively Develops Next-Generation Cell Therapy Products
2008-01-08
     1  2  3  4  5